← Eichor
Study identifier: NCT06357143 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Efficacy of Early Multimodal Physiotherapy in Patients With Reverse Shoulder Prosthesis

Condition: Shoulder Fractures · Prosthesis User  ·  Sponsor: University of Malaga

PhaseNA
Planned participants40
Who can joinAll sexes, 18 Years to 90 Years
Healthy volunteersNo

About this study

The present study try to evaluate the effectivenness of an early intervention program based on multimodal physiotherapy and focused on therapeutic exercise to improve the results of patients with a reverse shoulder phrostesis. This trial will be a randomized controlled trial with parallel groups, and outcomes variables will include psychometric properties through the use of specific questionnaries, and laboratory variables such as strength with a dynamometer, range of movement with a goniometer, muscle mass with an ultrasound, and kinematic parameters with inertial sensors. This study aims to develop an original intervention program in order to try to establish new protocols in the management of these patients.

This description comes directly from the study's public registry record.

Talk to the study team

Antonio I Cuesta-Vargas, PhD  ·  (+34) 667 45 55 44  ·  acuesta@uma.es

Always discuss trial participation with your own doctor first.

Locations (1)

Antonio Cuesta VargasMálaga, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06357143